Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18).
about
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infectionComplement and its role in protection and pathogenesis of flavivirus infectionsThe good and evil of complement activation in HIV-1 infectionComplement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infectionFunctional comparison of innate immune signaling pathways in primatesDetection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection.Complement opsonization of HIV-1 enhances the uptake by dendritic cells and involves the endocytic lectin and integrin receptor familiesA novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complementComplement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3A mathematical model of CR3/TLR2 crosstalk in the context of Francisella tularensis infection.Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions.Complement and HIV-I infection/HIV-associated neurocognitive disorders.Regulation of innate immune response to Candida albicans infections by αMβ2-Pra1p interaction.Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infectionComplement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells.Impaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1.Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors.CD11c/CD18 Dominates Adhesion of Human Monocytes, Macrophages and Dendritic Cells over CD11b/CD18Integrin αXβ₂ is a leukocyte receptor for Candida albicans and is essential for protection against fungal infections.Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linkedA Novel Role for the Receptor of the Complement Cleavage Fragment C5a, C5aR1, in CCR5-Mediated Entry of HIV into Macrophages.Humoral immunity to HIV-1: neutralization and beyond.Complement opsonization of HIV-1 results in a different intracellular processing pattern and enhanced MHC class I presentation by dendritic cells.HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting CellsThe versatile functions of complement C3-derived ligands.Evasion Mechanisms Used by Pathogens to Escape the Lectin Complement PathwayComplement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).Complement opsonization enhances friend virus infection of B cells and thereby amplifies the virus-specific CD8+ T cell responseComplement receptor 3 promotes severe ross river virus-induced disease.HIV-1 induced generation of C5a attracts immature dendriticcells and promotes infection of autologous T cells.C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells.Complement-Opsonized HIV-1 Alters Cross Talk Between Dendritic Cells and Natural Killer (NK) Cells to Inhibit NK Killing and to Upregulate PD-1, CXCR3, and CCR4 on T Cells.C-Type Lectin Receptors in Antiviral Immunity and Viral Escape.
P2860
Q21245045-A45EC1A3-40BF-43AD-88B5-410C4998A8F4Q27490236-09E3BFE9-14D5-4310-B18C-3021F386D023Q28275986-59AA606A-2D50-4D2F-8C92-4E9A0E0A8353Q28766705-8DA0CF6D-7CD0-4362-8463-F3AA656F0925Q33780976-05B5CC7A-A2E6-4F83-A2A2-0D65537D23CEQ33834852-D9E5134F-8470-44B0-95FD-90EFFEC97EB0Q33997250-25B4D124-D372-4C8E-85EE-1CAC85A73C43Q33997980-7728709A-2AC4-4192-BA91-25AD22F652B8Q34364911-DEDC8C9A-D735-4BB6-B85D-689266D4FF84Q34468902-622E1085-B00C-402B-AD20-16E76CF6B5F2Q34507239-C3A2CD66-3065-4300-ADB1-B99A0E8D76EEQ34610122-0EFBE7F0-F530-401F-AC78-CC9E33C0AABEQ34740272-B10115BB-BB9A-4491-9120-D50D54BCCBEDQ35363127-2DACA889-7490-4E4F-96D8-28BD511C8811Q35677445-C502C256-244A-465C-AFB9-8051C9449860Q35925669-FA7009FC-CF66-414E-8D69-328F99861B8CQ35952837-565187AD-6EDF-4502-878F-0EB790021BD6Q36141146-8FAFDE24-2376-4697-A58E-FDF99071329BQ36179813-586491BF-371A-490A-9ED9-9B59054FD17CQ36506821-9E4F650A-576A-4831-B17D-81DFD9F940EAQ36540060-79D930BB-C40E-4301-93D4-0F09DA50DF49Q36756266-A27F42D8-0CF3-4E68-A7D9-7EDF2C899944Q36863847-1A085617-E4FC-4923-8726-C3F21AC8EBC8Q37083678-38CD1BAB-5A2A-42BB-AF11-4052DB67BCC2Q37287774-723334B5-8A8D-4D8B-AF02-EB230E7C516CQ38991076-19D444D7-7D3C-40E2-8E7A-94805B4B29C3Q39335628-FCE5EDE2-AEC2-4477-A19E-0C39C05DF326Q40706471-1467BD1E-84F9-4A83-9DD6-209145A9AF7CQ41773067-CA8F7351-0CB6-460A-A0AD-B3ACEE99BB71Q43251027-F6438EEF-EC1D-4761-838A-35A6470519F4Q53544247-00B3DC2D-D1F2-494C-B95F-8110982F76AEQ53662172-348B2270-9FF6-4386-ABCF-7AEC523405E5Q54211943-52EDEBE7-38C9-47CC-AEAF-01BAB6FC9D03Q55444816-65B1F66C-72ED-4124-B09C-1A819D70EDCF
P2860
Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cutting edge: productive HIV-1 ...... ptor type 3 (CR3, CD11b/CD18).
@en
type
label
Cutting edge: productive HIV-1 ...... ptor type 3 (CR3, CD11b/CD18).
@en
prefLabel
Cutting edge: productive HIV-1 ...... ptor type 3 (CR3, CD11b/CD18).
@en
P2093
P1476
Cutting edge: productive HIV-1 ...... ptor type 3 (CR3, CD11b/CD18).
@en
P2093
Anna Erdei
Manfred P Dierich
Zsuzsa Bajtay
P304
P356
10.4049/JIMMUNOL.173.8.4775
P407
P577
2004-10-01T00:00:00Z